EFFICHRONIC study protocol: a non-controlled, multicentre European prospective study to measure the efficiency of a chronic disease self-management programme in socioeconomically vulnerable populations

Introduction More than 70% of world mortality is due to chronic conditions. Furthermore, it has been proven that social determinants have an enormous impact on both health-related behaviour and on the received attention from healthcare services. These determinants cause health inequalities. The obje...

Full description

Saved in:
Bibliographic Details
Main Authors: Hein Raat, Graham Baker, An L D Boone, Marta M Pisano-Gonzalez, Verushka Valsecchi, Siok Swan Tan, Yves-Marie Pers, Raquel Vazquez-Alvarez, Delia Peñacoba-Maestre, Alberto Pilotto, Sabrina Zora, Jose Ramón Hevia-Fernandez, Sergio Valles García, Sonia López-Villar, Inés Rey Hidalgo, Raquel Ochoa Gonzalez, Christian Jorgensen, Rosanna Ferreira, Adrien Durand, Cristina Balaguer Fernandez, Dallal Fracso, Danni Brown, Suzanne Lucas, Irene Fierloos, Xuxi Zhang, Petra de Vries, Alberto Ferri, Alberto Cella, Alessandra Argusti, Ascensión Doñate Martínez, Laura Llop Medina, Jorge Garcés
Format: Article
Language:English
Published: BMJ Publishing Group 2019-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/9/12/e032073.full
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction More than 70% of world mortality is due to chronic conditions. Furthermore, it has been proven that social determinants have an enormous impact on both health-related behaviour and on the received attention from healthcare services. These determinants cause health inequalities. The objective of this study is to reduce the burden of chronic diseases in five European regions, hereby focusing on vulnerable populations, and to increase the sustainability of health systems by implementing a chronic disease self-management programme (CDSMP).Methods and analysis 2000 people with chronic conditions or informal caregivers belonging to vulnerable populations, will be enrolled in the CDSMP in Spain, Italy, the UK, France and the Netherlands. Inclusion of patients will be based on geographical, socioeconomic and clinical stratification processes. The programme will be evaluated in terms of self-efficacy, quality of life and cost-effectiveness using a combination of validated questionnaires at baseline and 6 months from baseline.Ethics and dissemination This study will follow the directives of the Helsinki Declaration and will adhere to the European Union General Data Protection Regulation. The project’s activities, progress and outcomes will be disseminated via promotional materials, the use of mass media, online activities, presentations at events and scientific publications.Trial registration number ISRCTN70517103; Pre-results.
ISSN:2044-6055